| Caffeine enhances osteoclast differentiation from bone marrow hematopoietic cells and reduces bone mineral density in growing rats SH Liu, C Chen, RS Yang, YP Yen, YT Yang, C Tsai Journal of Orthopaedic Research 29 (6), 954-960, 2011 | 103 | 2011 |
| Sorafenib and Doxorubicin Show Synergistic Effects in Human and Canine Osteosarcoma Cell Lines YT Yang, V Yuzbasiyan-Gurkan International Journal of Molecular Sciences 23 (16), 9345, 2022 | 5 | 2022 |
| Small Molecule 20S Proteasome Enhancer Regulates MYC Protein Stability and Exhibits Antitumor Activity in Multiple Myeloma JJT E. Njomen, A. Vanecek, T.A. Lansdell, Y.-T. Yang, P.Z. Schall, C.M ... Biomedicines 10, 938, 2022 | 5 | 2022 |
| Enhancing c-MYC degradation via 20S proteasome activation induces in vivo anti-tumor efficacy E Njomen, TA Lansdell, A Vanecek, V Benham, MP Bernard, YT Yang, ... bioRxiv, 2020.08. 24.265470, 2020 | 2 | 2020 |
| Identification of a Hypomorphic FANCG Variant in Bernese Mountain Dogs K Meek, YT Yang, M Takada, M Parys, M Richter, AI Engleberg, ... Genes 13 (10), 1693, 2022 | 1 | 2022 |
| ATP7A, ATP7B, and RETN genotypes in Labrador Retrievers with and without copper-associated hepatopathy DK Langlois, BSM Nagler, RC Smedley, YT Yang, V Yuzbasiyan-Gurkan Journal of the American Veterinary Medical Association 260 (14), 1-8, 2022 | 1 | 2022 |
| Establishment and Characterization of Cell Lines from Canine Metastatic Osteosarcoma YT Yang, AI Engleberg, V Yuzbasiyan-Gurkan Cells 13 (1), 25, 2023 | | 2023 |
| Identification of Novel Treatment Approaches for Human and Canine Osteosarcoma YT Yang Michigan State University, 2020 | | 2020 |
| Targeting c-MYCdegradation as a novel therapeutic strategy for osteosarcoma: Studies in canine and human osteosarcoma cells YT Yang, V Yuzbasiyan-Gurkan, JJ Tepe Cancer Research 79 (13_Supplement), 4729-4729, 2019 | | 2019 |
| Synergistic effects of tyrosine kinase inhibitors and conventional chemotherapeutics on canine and human osteosarcoma cells YT Yang, V Yuzbasiyan-Gurkan Cancer Research 78 (13_Supplement), 2949-2949, 2018 | | 2018 |
| Synergistic effects of Bortezomib and JQ1 for human and canine osteosarcoma treatments YT Yang, V Yuzbasiyan-Gurkan Cancer Research 77 (13_Supplement), 4032-4032, 2017 | | 2017 |
| Detection of circulating tumor cells in osteosarcoma: A validation study using a translational model M Takada, YT Yang, H Piegols, PV Saavedra, CM Tang, P Amstutz, ... Cancer Research 77 (13_Supplement), 3921-3921, 2017 | | 2017 |
| Evaluation of JQ1 as a cytotoxic agent in canine sarcoma cell lines YT Yang, M Takada, V Yuzbasiyan-Gurkan MOLECULAR CANCER RESEARCH 13, 2015 | | 2015 |
| Abstract B46: Evaluation of JQ1 as a cytotoxic agent in canine sarcoma cell lines YT Yang, M Takada, V Yuzbasiyan-Gurkan Molecular Cancer Therapeutics 13 (10_Supplement), B46-B46, 2015 | | 2015 |
| Bortezomib and JQ1 hold promise for human and canine osteosarcoma Y Yang, V Yuzbasiyan-Gurkan Cancer Research 75 (15_Supplement), 1749-1749, 2015 | | 2015 |
| Search for effective therapies for canine and human osteosarcoma using novel therapeutic agents Y Yang, E Bartczak, V Yuzbasiyan-Gurkan Cancer Research 74 (19_Supplement), 1752-1752, 2014 | | 2014 |
| The search for the stem cells of human and canine osteosarcoma: evaluation of stemness markers and sarcosphere formation. YT Yang, V Yuzbasiyan-Gurkan Cancer Research 73 (8_Supplement), 4910-4910, 2013 | | 2013 |
